EuroFlow develops and standardizes fast, accurate, and highly sensitive flow cytometric tests for diagnosis and prognostic (sub)classification of hematological malignancies as well as for evaluation of treatment effectiveness during follow-up. In addition to innovation, EuroFlow offers a number of services to improve the quality of diagnostics in the field of hemato-oncology worldwide, including Educational workshops, development of educational materials, organization of QA rounds and distribution of standardized protocols.
The EuroFlow Consortium consists of 19 diagnostic research groups, which are regarded as experts in the fields of flow cytometric and molecular diagnostics. Together these groups have sufficient complementarity and congruence to cover all aspects of innovation, standardization, and validation of highly sensitive flow cytometric tests for diagnosis and follow-up.
Registration is open!
Join us to explore the EuroFlow principles and discover our latest advancements. This workshop will showcase newly developed tools and panels designed for the precise diagnosis and monitoring of hematological malignancies.
From 19 through 21 February, EuroFlow organizes the 1st EuroFlow Winter Course on Minimal Residual Disease (MRD) in Prague, Czech Republic.
The EuroFlow Winter Course on MRD is designed as hands-on, case-based intensive training for already experienced clinical cytometrists, introducing them to the EuroFlow procedures, analysis of the EuroFlow panels and use of its associated databases in Infinicyt.
Registrations will open soon!
Twice per year, EuroFlow organizes an external Quality Assessment program. Labs around the world can join this program to evaluate their whole flow cytometric analysis process and obtain a certificate upon good performance.
News
ESLHO, together with the independent scientific foundations EuroFlow, EuroClonality and EuroMRD, is an official EHA Specialized Working Group (SWG).